NACDS participates in White House Roundtable on Inflation Reduction Act
On Tuesday, at the invitation of U.S.
Pharmacy
Aurobindo gets FDA approval for apremilast tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application apremilast tablets, 10mg, 20mg, and 30mg.
Aurobindo receives FDA approval for hydrocortisone tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Hydrocortisone Tablets USP, 5 mg, 10mg, and 20mg.
Aetna community investment takes lifesaving maternity program across Kansas
A program aimed at eradicating preventable infant death and improving birth outcomes will soon be available across the Sunflower State.
LexisNexis Reed Tech expands portfolio
LexisNexis Reed Tech, a leading provider of regulatory submissions, data management and analytics solutions for the life sciences industry, is expanding its services portfolio to offer end-to-end eCTD solutions and services to support manufacturers, distributors and related operations.
Position nutraceuticals as complements to O-T-Cs
In a retail pharmacy, between the food and beverage aisles and the prescription drugs, consumers can find two kinds of health products: over-the-counter medicines and nutraceuticals.
Dr. Reddy’s Walton on relationships with drug chains
With the end of the public health emergency, Dr. Reddy’s Laboratories has assessed the pandemic’s effect on its interactions with drug chains and how the COVID years will impact future relationships.
Speeding biologics R&D with software, data flows
the Center for Biologics Evaluation and Research (CBER) — approved a
AI can help pharmacies cut costs and boost revenue
It’s well known that beyond their role in filling prescriptions as an essential link between health care providers and patients, retail pharmacies have long offered a broad range of products aimed at helping people to maintain their health.
Eli Lilly’s experimental Alzheimer’s drug slows progression of the disease
Eli Lilly and Co. presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer’s disease (AD).
Journalist Ron Brownstein to speak during 2023 NACDS Total Store Expo
senior political analyst for CNN, senior editor for The Atlantic and contributing editor for National Journal — will speak at the NACDS Political Involvement Reception during the 2023 NACDS Total Store Expo, which will be held August 12-14 in San Diego, Calif. NACDS president
NACDS commends Senate Finance Committee for scheduling PBM reform bill markup
WASHINGTON – The National Association of Chain Drug Stores (NACDS) is applauding the U.S. Senate Committee on Finance for scheduling action on pharmacy benefit manager (PBM) reform.
RedSail Technologies announces integration between Axys and Etactics
RedSail Technologies, developer of Axys, is proud to announce the launch of its integration with Etactics, a premier revenue cycle management platform.
Revelation Pharma completes two acquisitions
TAMPA – Osceola Capital announced today the seventeenth and eighteenth additions to the Revelation Pharma platform, adding significant scale and capabilities to the business.
Aurobindo receives FDA approval for sevelamer hydrochloride tablets
Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application sevelamer hydrochloride tablets 400mg and 800mg.